You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR OMIDENEPAG ISOPROPYL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for omidenepag isopropyl

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05279716 ↗	Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl	Recruiting	Santen Pharmaceutical Asia Pte. Ltd.	Phase 4	2022-02-15	This study is for patients have been using prostaglandin analogue eye drops with a preservative for 3 months or more and have been diagnosed with prostaglandin-associated peri-orbital disease. the investigators would like to confirm the real world evidence(RWE) of safety and efficacy after changing to Eybelis ophthalmic solution 0.002%.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for omidenepag isopropyl

Condition Name

Chart
Table

Condition Name for omidenepag isopropyl
Intervention	Trials
Glaucoma, Suspect	1
Normal Tension Glaucoma	1
Ocular Hypertension	1
Primary Open-angle Glaucoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for omidenepag isopropyl
Intervention	Trials
Ocular Hypertension	1
Low Tension Glaucoma	1
Hypertension	1
Glaucoma, Open-Angle	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for omidenepag isopropyl

Trials by Country

Map
Table

Trials by Country for omidenepag isopropyl
Location	Trials
Korea, Republic of	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for omidenepag isopropyl

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for omidenepag isopropyl
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for omidenepag isopropyl
Clinical Trial Phase	Trials
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for omidenepag isopropyl

Sponsor Name

Chart
Table

Sponsor Name for omidenepag isopropyl
Sponsor	Trials
Santen Pharmaceutical Asia Pte. Ltd.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for omidenepag isopropyl
Sponsor	Trials
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.